Regarding the statute of limitations for the case of the investor v. Xinjiang Tianshan Animal Husbandry and Bioengineering Co., Ltd. ***ST Tianshan, 300313)** Misrepresentation Liability Dispute Only has the last 3 months left. Eligible injured investors are reminded to sign up for a claim as soon as possible. The Urumqi Intermediate People's Court has made a first-instance judgment on the claim, and the investor has won the case.
Tianshan Biotech (*ST Tianshan, 300313) disclosed in the "2023 Semi-Annual Report" that the court ruled in the first-instance trial that the listed company should compensate investors for losses totaling 172130,000 yuan. The company appealed against the judgment, but the second instance has not yet been applied. In addition, 11 investors filed a claim lawsuit for investment losses, including commissions, stamp duty, etc.
The statute of limitations for Tianshan Biotech (*ST Tianshan, 300313) is nearing the end of its claim, and investors who have previously won the judgment and subsequently participate in the claim have a high probability of winning the lawsuit. Based on the current situation, the conditions for the claim in this case are: investors who lost money by selling or still owning ** Tianshan Biotech (*ST Tianshan, 300313) between August 15, 2017 and January 23, 2019 and selling or still owning the ** after January 24, 2019. If you miss this time, you will no longer have the right to prevail.